Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia
Phase 2 Completed
75 enrolled 14 charts
Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R
Phase 2 Completed
60 enrolled 9 charts
Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)
Phase 2 Completed
273 enrolled
IDASPHERE II
Phase 2 Completed
46 enrolled 11 charts
Efficacy of Idarubicin, Cytarabine and Cyclophosphamide (IAC) Regimen in Relapsed/Refractory AML
Phase 2 Completed
20 enrolled
Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia
Phase 2 Completed
16 enrolled 9 charts
Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)
Phase 2 Completed
11 enrolled 12 charts
Risk-adapted Therapy for Primary Acute Myeloid Leukemia
Phase 2 Completed
1,034 enrolled
A Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)
Phase 2 Completed
42 enrolled 16 charts
Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia
Phase 2 Completed
27 enrolled 9 charts
azacitidine
Phase 2 Completed
277 enrolled
Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML)
Phase 2 Completed
116 enrolled 10 charts
Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AML
Phase 2 Completed
42 enrolled 12 charts
A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Phase 2 Completed
24 enrolled 13 charts
LAL0904
Phase 2 Completed
470 enrolled 10 charts
Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction
Phase 2 Completed
63 enrolled 6 charts
Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
Phase 2 Completed
175 enrolled 9 charts
E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes
Phase 2 Completed
43 enrolled 11 charts
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
Phase 2 Completed
52 enrolled 17 charts
Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma
Phase 2 Completed
20 enrolled
Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
Phase 2 Completed
111 enrolled 7 charts
Efficacy and Toxicity of Increasing Doses of Idarubicin, Cytarabine and G-CSF in Acute Myeloid Leukemia
Phase 2 Completed
48 enrolled
Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Phase 2 Completed
106 enrolled 6 charts
Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML
Phase 2 Completed
53 enrolled
Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
Phase 2 Completed
36 enrolled
A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia
Phase 2 Completed
51 enrolled
Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
Phase 2 Completed
60 enrolled
Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission
Phase 2 Completed
40 enrolled
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia
Phase 2 Completed
Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia
Phase 2 Completed
35 enrolled
Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia
Phase 2 Completed
53 enrolled
Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
Phase 2 Completed
106 enrolled
m-FLAI
Phase 2 Completed
108 enrolled
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis
Phase 2 Completed